Basis by Elysium Health Helps Sustain Cellular Health

Since it first launched in 2015, Elysium Health Basis has been one of the most exciting daily supplements to hit the market. One feature that makes this product unique is its focus on supporting health at the cellular level.

Improving Health from the Bottom Up

Basis is designed to support cellular health by boosting the levels of the coenzyme nicotinamide adenine dinucleotide, or NAD, in the body. NAD+ plays a crucial role in many biological processes, including  DNA maintenance, energy creation and circadian rhythms.

How Basis Works

As the body ages, NAD+ levels decline. As a result, the functions that are supported by this coenzyme also start to slow down. Basis is proven to increase and sustain levels of NAD+.

Basis promotes overall health through the two primary compounds that make up each capsule. The compounds are, nicotinamide riboside, a direct precursor to the coenzyme NAD+, which the body uses to power metabolism, and pterostilbene, a powerful and bioavailable polyphenol similar to resveratrol, but more bioavailable.  

Elysium Health’s Crowning Jewel

Basis is the first product created by the consumer health company Elysium Health. With a particular focus on proactive health, Elysium Health is committed to translating advances in science and technology into clinically-validated health products that work.

Elysium Health has invested in a vertically-integrated supply chain to ensure the consistency and exceptional quality of every capsule of Basis, and we use industry-leading standards for safety testing.

Who Can Use Basis

Basis is designed primarily for adults of all ages and can be used on a long-term basis. It is also safe for use among people with dietary limitations since it is gluten-free, vegan, vegetarian, and nut-free. Basis also  contains no artificial flavors or colors.

Available Subscription Options

If you want to try out Basis, adults are advised to take two capsules on a daily basis. The most popular subscription plan is $270 for six months ($45 per month); you can also try Basis for a year for $480 ($40 per month), on a monthly plan for $50 per month, or an individual  bottle for $60.

Achieve Better Cellular Health

Elysium Health’s stellar reputation as a health company committed to helping people live healthier, longer and the science behind Basis are strong reasons to start taking this supplement now.

Omar Boraie, Angel of Precision Medicine Research

New Brunswick developer Omar Boraie is funding scientific progress with a $1.5 million pledge toward research in precision medicine. In a report by, the Omar Boraie Chair in Genomic Science provides for research in a relatively new field, that of analyzing and treating tumors at a genetic level. Developed under the auspices of Rutgers Cancer Institute of New Jersey, the chair will explore the application of highly customized therapies for patients with limited treatment options.

Boraie hopes for precision medicine to be applied to all cancer patients. Rutgers Cancer Institute Director Robert S. DiPaola, MD expressed gratitude and optimism toward the success of Boraie’s goal. President Obama emphasized the same belief in his 2015 State of the Union address when announcing the new Precision Medicine Initiative.

Shridar Ganesan, MD, Ph.D., has been named to the Omar Boraie Chair and comes uniquely qualified to lead the work. Doctor Ganesan is a highly regarded medical oncologist and academic researcher. He is the associate director for transitional science, associate professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School, and leader of the precision medicine clinical trial at Rutgers.

According to Ganesan cancer is not one but many diseases, each with its own unique features. Rather than lumping each cancer into categories based on location in the body, he views genomic analysis as a means to exactly tailor treatment individually. Along with Mr. Boraie, Dr. Ganesan hopes to discover new understanding that will benefit even the most challenging cases.

Rutgers Cancer Institute of New Jersey is a leader in research, prevention, and treatment of cancer. The National Cancer Institute has designated Rutgers a Comprehensive Cancer Center, the first and only one in in the state. Research carried out by Rutgers is geared toward the practical application of discoveries into clinical applications.

This article was originally published through NewsWise, and can be read in full at this link.

See Omar Borie’s bio on